Resmed Inc. buy Morgan Stanley
Start price
27.10.23
/
50%
€126.35
Target price
27.10.24
€160.06
Performance (%)
53.18%
Price
25.07.24
€192.20
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Resmed Inc. has seen massive gains of 53.18%. A total of €1.34 was paid as dividends for this prediction. This prediction currently runs until 27.10.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Resmed Inc. | 1.062% | 1.062% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $169.00 price target on the stock, down previously from $180.00.
Ratings data for RMD provided by MarketBeat